Akèy › Maladi Alzheimer › Texas
Etid klinik pou Maladi Alzheimer nan Texas
40 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan Texas.
Vil nan Texas
- Houston12 etid
- Dallas12 etid
- San Antonio10 etid
- Austin10 etid
- Cypress7 etid
- Beaumont6 etid
- Round Rock4 etid
- El Paso4 etid
Tèks ofisyèl etid la (Anglè)
NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE
- Baylor College of Medicine, Houston
Ap rekrite
Laj 55 a 90 · Tout sèks · Mizajou Oct 1, 2026 · NCT07667478A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Austin
- Clinical Site, McKinney
- Clinical Site, Sugarland
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Horizon Clinical Research Group, Cypress
- University of Texas Health Science Center at San Antonio, San Antonio
Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Epic Medical Research, LLC - Carrolton, Carrollton
- Local Institution - 2605, Cypress
- Local Institution - 1643, El Paso
- ak 2 plis
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 28, 2026 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Mt. Olympus Medical Research, Llc - Katy, Katy
Ap rekriteFaz 4
Laj 50 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07633470Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
- Houston Methodist Research Institute, Houston
Ap rekriteFaz 1/2
Laj 50 a 86 · Tout sèks · Mizajou Sep 23, 2026 · NCT07651319A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Gadolin Research, Beaumont
- Kerwin Medical Center, Dallas
- Houston Methodist Hospital, Houston
- ak 3 plis
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- Kerwin Medical Center- Site Number : 8400006, Dallas
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07688213A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Senior Adults Specialty Research, Austin
- Local Institution - 1260, Dallas
- Epic Medical Research LLC - DeSoto, DeSoto
- ak 5 plis
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Kerwin Research Center, LLC - Oak Cliff, Dallas
- Kerwin Research Center, LLC in Texas, Dallas
Ap rekriteFaz 2
Laj 55 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Gadolin Research, LLC, Beaumont
- South Texas Research Institute - Brownsville, Brownsville
- Kerwin Medical Center, Dallas
- ak 6 plis
Ap rekriteFaz 3
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Kerwin Medical Center /ID# 277788, Dallas
Ap rekriteFaz 1/2
Laj 50 a 90 · Tout sèks · Mizajou Sep 18, 2026 · NCT07599670A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Local Institution - 0081, Dallas
- Central Texas Neurology Consultants, PA, Round Rock
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Sep 17, 2026 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Epic Medical Research, LLC - Carrolton, Carrollton
- Horizon Clinical Research Center - Houston, Cypress
- Epic Medical Research, LLC - Mesquite, Mesquite
- ak 1 plis
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07011745A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Advanced Neurology Epilepsy and Sleep Center, El Paso
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07011732Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline
- Health Discovery Building, Austin
Ap rekriteVolontè an sante akeyi
Laj 18 a 90 · Tout sèks · Mizajou Sep 2, 2026 · NCT05907343Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Pinnacle Clinical Research, Austin
- Horizon Clinical Research Center - Houston, Cypress
- ANESC Research, El Paso
- ak 3 plis
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 1, 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Gadolin Research ( Site 1032), Beaumont
- Horizon Clinical Research Center - Houston ( Site 1026), Cypress
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Aug 26, 2026 · NCT07033494A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Gadolin Research, Beaumont
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Aug 20, 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- National Neuromuscular Research Institute, Austin
- University of Texas Southwestern, Dallas
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Kerwin Research and Memory Center, Dallas
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Kerwin Research and Memory Center, Dallas
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05552157A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Senior Adults Specialty Research, Austin
- Gadolin Research, Beaumont
- The University of Texas Health Science Center at Houston, Houston
- ak 1 plis
Ap rekriteFaz 3
Laj 55 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07602582Epidemiology and Biomarker Study in Alzheimer's Disease
- Care Access - Houston, Houston
Ap rekriteFaz 3Volontè an sante akeyi
Laj 55 a 75 · Tout sèks · Mizajou Jul 7, 2026 · NCT07142954A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- University of Texas Health Science Center at San Antonio, San Antonio
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Jun 26, 2026 · NCT07094516Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
- University of Texas at Austin, Austin
Ap rekriteVolontè an sante akeyi
Laj 40 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT05741853Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia
- University of Texas at Austin, Austin
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06511752[18F]PI-2620 Phase 3 Histopathological Study
- Baylor Research Institute, Dallas
- Sante Clinical Research, Kerrville
- Be Well Clinical Studies, Round Rock
Ap rekriteFaz 3
Laj 50 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- University of Texas Health San Antonio, Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, San Antonio
Ap rekriteEtid obsèvasyon
Laj 25 a 55 · Tout sèks · Mizajou May 18, 2026 · NCT04165109Late Onset Alzheimer's Disease
- University of Texas Southwestern, Dallas
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT05010603Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease
- Michael E. DeBakey VA Medical Center, Houston
Ap rekrite
Laj 65 a 85 · Tout sèks · Mizajou May 7, 2026 · NCT06835283δ in Dementia Clinical Trials
- Univeristy of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio
Ap rekrite
Laj 65 a 100 · Tout sèks · Mizajou May 5, 2026 · NCT05592678Stem Cell Therapy for Early Alzheimer's Disease
- The University of Texas Health Science Center at Houston (UTHealth), Houston
Ap rekriteFaz 1/2
Laj 60 a 80 · Tout sèks · Mizajou Apr 20, 2026 · NCT06775964Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Gadolin Research LLC, Beaumont
- Re:Cognition Health, Houston
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 60 a 90 · Tout sèks · Mizajou Apr 15, 2026 · NCT06584357Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
- Houston Methodist Research Institute, Houston
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 90 · Tout sèks · Mizajou Apr 6, 2026 · NCT05582200Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms
- University of Texas Health Science Center at San Antonio, San Antonio
Ap rekrite
Laj 60 a 85 · Tout sèks · Mizajou Feb 11, 2026 · NCT06801639Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Houston
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Feb 2, 2026 · NCT07105709Paper-Based and Smartphone-Based Memory Supports
- UT Health Austin Comprehensive Memory Center, Austin
- Baylor Scott & White Healthcare, Temple
- Baylor University, Waco
Ap rekrite
Laj 50 ak plis · Tout sèks · Mizajou Jul 9, 2024 · NCT06444841Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- Caraday Healthcare, LLC, San Marcos
Ap rekrite
Laj 50 ak plis · Tout sèks · Mizajou Mar 12, 2024 · NCT05820919Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- The University of Texas at Austin, Austin
Ap rekriteFaz 4
Laj 55 ak plis · Tout sèks · Mizajou May 18, 2022 · NCT03082755Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.